Enflame Wins Approval for $883 Million STAR Market IPO

China’s securities regulator has approved Tencent-backed AI chip startup Shanghai Enflame Technology Co. Ltd.’s application for an initial public offering on Shanghai’s STAR Market, where the company plans to raise 6 billion yuan ($883 million). The approval, granted on July 9, marks the completion of all regulatory review procedures for the company’s listing and positions Enflame as the fourth and final member of China’s elite “four GPU little dragons” to gain access to public capital markets.

According to Caixin Global, the listing represents another significant step in the commercialization of China’s homegrown AI chip sector, as domestic suppliers move to capture demand created by U.S. restrictions on advanced foreign processors.

Background and Company History

Founded in March 2018 by former AMD engineers Zhao Lidong and Zhang Yalin, Enflame develops cloud AI training and inference chips, accelerator cards, server clusters, and full-stack software platforms. The company has completed four generations of self-developed GCU (General Computing Unit) chips and is headquartered in Shanghai. As Wikipedia notes, the company has been compared to Nvidia due to their similar focus on high-performance AI computing.

Enflame is the last of China’s “four GPU little dragons” — a group of domestic AI chip startups that includes Moore Threads (listed on STAR Market in December 2025, up 425% from its offer price), Biren Technology (listed on the Hong Kong Stock Exchange), and MetaX/Muxi (listed on STAR Market in May 2026 with strong first-day performance).

IPO Timeline and Use of Funds

The IPO approval process moved with notable efficiency. DRAMeXchange reports that Enflame’s application was formally accepted by the Shanghai Stock Exchange on January 22, 2026, entered the Q&A stage in February, passed the listing committee review on June 15, submitted full registration materials on June 18, and received CSRC approval just 21 days later on July 9. The sponsor for the IPO is CITIC Securities, and the approval is valid for 12 months.

The 6 billion yuan raised will be allocated to three core projects: 1.3534 billion yuan for 5th-gen AI chip R&D and industrialization, 1.1966 billion yuan for 6th-gen AI chip R&D and mass production, and 3.3002 billion yuan for advanced AI software-hardware collaborative innovation projects.

Financial Performance and the Tencent Factor

Enflame’s financial trajectory shows steady improvement. Revenue grew from 301 million yuan in 2023 to 722 million yuan in 2024, reaching 990 million yuan in 2025. Net losses narrowed from 1.6 billion yuan to 1.2 billion yuan over the same period. In the first quarter of 2026, revenue jumped 1,475% year-on-year to 287 million yuan, while the net loss narrowed 38% to 444 million yuan. Cumulative losses as of the end of 2025 stood at 4.4 billion yuan (~$600 million). The company expects to turn profitable in 2026 or 2027.

However, Enflame’s most distinctive — and potentially most vulnerable — characteristic is its deep relationship with Tencent. As The Next Web reports, Tencent holds approximately 20.3% equity in Enflame and accounted for 83.8% of the company’s 2025 revenue, or roughly 830 million yuan out of 990 million yuan total. Tencent pre-funds Enflame’s roadmap with orders, which has enabled the startup to ship advanced silicon despite holding barely 1% of China’s market. The company says Tencent’s demand has “far exceeded” what it can supply.

But as The Next Web notes, “a chipmaker that leans on one client for most of its sales is exposed if that client’s priorities shift, and the relationship already squeezes Enflame’s prices.”

Technology Gap and Market Context

Despite rapid progress, Chinese AI chipmakers face significant technological hurdles. According to ChosunBiz, Chinese AI chip companies trail Nvidia by approximately five years in training chips and three years in inference chips. Some analysts say the gap feels even larger when factoring in software ecosystems and mass-production capabilities.

Nevertheless, market enthusiasm for domestic AI chip stocks remains high. The STAR 50 Index rose 8.4% on July 10, fueled in part by Enflame’s IPO approval news. The strong performance of earlier AI chip IPOs — Moore Threads up 425%, Biren up 150%+ — suggests significant investor appetite for Chinese domestic chip companies.

Geopolitical Significance

Enflame’s IPO is not merely a corporate event but a strategic milestone in the US-China technology competition. In late 2023, Enflame submitted downgraded chip designs to TSMC to comply with U.S. export restrictions. The company sells chips to state-owned enterprises and has cooperated with local governments on AI computing projects. China has also loosened STAR Market listing rules to allow loss-making hardware companies to go public, enabling the wave of AI chip IPOs as part of Beijing’s broader strategy to channel capital markets toward strategic technology sectors.

What’s Next

With all four of China’s leading domestic GPU startups now having gained access to public capital markets, the focus shifts to execution. Enflame must navigate the challenge of diversifying its customer base beyond Tencent, closing the technology gap with Nvidia, and achieving its projected path to profitability. The company’s IPO pricing and demand will serve as a key test of investor conviction in China’s AI-chip-independence story.

As The Next Web aptly summarized: “The float is a referendum. Its pricing and demand will show how much conviction Chinese institutions really have in the country’s AI-chip-independence story, and whether that conviction survives a hard look at a balance sheet carrying $600m in losses and a customer list of essentially one.”